webinar register page

Webinar banner
CLL treatment in the relapsed-refractory setting and promising therapeutic approaches to fulfil unmet needs
This educational session will discuss advances in how relapsed/refractory CLL patients and those who fail a treatment are treated today. What therapies are used for subsequent treatments and what promising new developments may fulfil unmet treatment needs?

During this session we will explore:
- Fixed term and continuous treatments
- Solutions in the multiple-relapsed-refractory group
- Overcoming challenges for the clinician and the patient
- New technologies
- Treatment sequencing

By registering for this webinar you will automatically be enrolled in receiving our email communications about our services.
* Required information


Nick York
Patient Advocacy Healthcare Liaison Officer @Leukaemia Care (UK)
Dr Talha Munir
Consultant Haematologist @Leeds Teaching Hospitals NHS Trust (UK)
Dr Brian Koffman
Co-Founder, Executive VP and Chief Medical Officer @CLL Society (US)
Lelia Duley
Associate Trustee @CLL Support (UK)